LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--E-Z-EM, Inc. (NASDAQ:EZEM) today announced that the Company has received clearance from the Food and Drug Administration for its EmpowerSyncTM system—a product based on the CAN-CiA (Controller Area Network-CAN in Automation) DSP 425 protocol. EmpowerSync permits synchronized operation of EmpowerCT® and EmpowerCTA® injector systems and CT scanners from all of the manufacturers who also adopt the DSP 425 standard. E-Z-EM is exhibiting EmpowerSync at the Radiological Society of North America (RSNA) meeting in Chicago from November 26 to December 1
.
